Innovation Intergroup visits MIND and HT
14 September 2020 – An opportunity for dialogue and discussion today at MIND and Palazzo Italia between a selection of Members of Parliament, part of the Innovation Intergroup led by Hon. Nicolò Invidia and MIND partners.
The first part of the meeting was attended by Igor De Biasio, Arexpo CEO, Andrea Ruckstuhl, EMEA Lendlease Director, Stefano Minnini MIND Project Coordinator Lendlease, Massimo Minelli, President of the Triulza Foundation and Elena Bottinelli, CEO, IRCCS Istituto Ortopedico Galeazzi to present evolution of the project from EXPO Milano 2015 to today.
The visit continued at Palazzo Italia where MPs had the opportunity to meet Human Technopole director Iain Mattaj who stressed the importance of the research project to attract back to Italy the best scientific talents and help strengthen the national ecosystem.
The meeting was attended by Prof. Alessandro Vannini, Dr. Gaia Pigino, Dr. Paolo Swuec, Prof. Giuseppe Testa, dr. Florian Jug and Dr. Francesco Iorio.
Share:
You could also like:
-
From RNA to proteins: AIRC supports Human Technopole’s new approaches to cancer research
Lorenzo Calviello and his group of the Human Technopole’s Research Centres for Genomics and Computational Biology have been awarded a five-year My First AIRC Grant by Fondazione AIRC per la Ricerca sul Cancro. The grant provides over €99,000 for 2026, for a total of €500,000, to support a project aimed at identifying cancer-specific proteins that could serve as new immunotherapy targets in colorectal cancer.
-
How sortilin senses thyroglobulin along its pathway to thyroid hormone release
Human Technopole researchers have identified the molecular mechanisms by which the membrane receptor sortilin binds thyroglobulin along its pathway to the release of thyroid hormones within the thyroid gland. The results of the research were published in Nature Communications and highlight that sortilin senses thyroglobulin via a short flexible “tag” which appears to be a common motif for the recognition of other partner proteins throughout our body.
-
AI4Life: A European Success for Artificial Intelligence in the Life Sciences
The AI4Life project, co-led by Florian Jug (Computational Biology Research Centre at Human Technopole) and Anna Kreshuk (EMBL), received the highest possible score in the European Commission’s final review, recognising its scientific impact and the quality of its achievements in applying artificial intelligence to biological image analysis.
-
Human Technopole awarded FIS grant for precision immunotherapy research
The Giustacchini Group of the Genomics Research Centre of Human Technopole has been awarded a €1.66 million grant from the Fondo Italiano per la Scienza (FIS 2) to advance precision immunotherapy for haematological malignancies. The three-year project, titled “Tailoring Precision Immunotherapy to Haematological Malignancies”, aims to develop more effective cell-based therapies for blood cancers by integrating molecular, cellular and systems-level analyses.
-
Highlights from the 2nd Conference “Future Trends in Translational Medicine”
Turning scientific discoveries into real-world therapies was the focus of the second international conference “Future Trends in Translational Medicine – From Molecules to Therapies,” held at the Complesso Universitario di San Giovanni a Teduccio in Naples on 30 -31 October 2025.